Neutrophil–cytokine interactions in a rat model of sulindac-induced idiosyncratic liver injury
Authors:
- Robert A. RothRRRobert A. Roth
- Husam S. YounisHYHusam S. Younis
- Ernst MalleEMErnst Malle
- Patricia E. GaneyPGPatricia E. Ganey
- 1 December 2011
- journal article
- Published by Elsevier in Toxicology
- Vol. 290 (2-3) , 278-285
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (DK061315, GM075865)
- Austrian Science Fund (P19074-B05)
This publication has 43 references indexed in Scilit:
- Oxidative stress is important in the pathogenesis of liver injury induced by sulindac and lipopolysaccharide cotreatmentToxicology, 2010
- Increased Hepatic Myeloperoxidase Activity in Obese Subjects with Nonalcoholic SteatohepatitisThe American Journal of Pathology, 2009
- Sulindac Metabolism and Synergy with Tumor Necrosis Factor-α in a Drug-Inflammation Interaction Model of Idiosyncratic Liver InjuryThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Trovafloxacin Enhances the Inflammatory Response to a Gram-Negative or a Gram-Positive Bacterial Stimulus, Resulting in Neutrophil-Dependent Liver Injury in MiceThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Plasminogen activator inhibitor-1 regulates neutrophil influx during acute pyelonephritisKidney International, 2009
- Tumor Necrosis Factorα Is a Proximal Mediator of Synergistic Hepatotoxicity from Trovafloxacin/Lipopolysaccharide CoexposureThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Hepatotoxic Interaction of Sulindac with Lipopolysaccharide: Role of the Hemostatic SystemToxicological Sciences, 2008
- Idiosyncratic drug hepatotoxicityNature Reviews Drug Discovery, 2005
- Adverse hepatic drug reactions: inflammatory episodes as consequence and contributorChemico-Biological Interactions, 2004
- Immunologic Detection and Measurement of Hypochlorite-Modified LDL With Specific Monoclonal AntibodiesArteriosclerosis, Thrombosis, and Vascular Biology, 1995